Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
07/2003
07/01/2003US6585968 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
07/01/2003CA2067469C Recombinant vaccine against marek's disease
07/01/2003CA2066387C Viral products
06/2003
06/26/2003WO2003052052A2 Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor
06/26/2003WO2003052051A2 Adeno-associated virus (aav) serotype 8 sequences
06/26/2003WO2002044406A3 Projection against mycobacterial infections
06/26/2003WO2002016412A3 Binding polypeptides for b lymphocyte stimulator protein (blys)
06/26/2003US20030119782 Method of treating and preventing infectious diesases
06/26/2003US20030119764 Analog is incorporated by a polymerase into an RNA copy of a genomic nucleic acid encoding the virus, and replaces a first natural occurring nucleotide having a first complementary nucleotide
06/26/2003US20030119192 Complementing cell lines
06/26/2003US20030119191 Compositions and methods for helper-free production of recombinant adeno-associated viruses
06/26/2003US20030119183 Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process
06/26/2003US20030119182 Immunotherapy; genetic engineering; anticancer agents
06/26/2003US20030119170 Porcine reproductive and respiratory syndrome vaccine, based on isolate JA-142
06/26/2003US20030119165 Plant transcription factors
06/26/2003US20030119029 Apoptosis, autoimmune diseases, antiproliferative agents, antiinflammatory agents, anticancer agents
06/26/2003US20030118611 Epitopes confirmed to be recognized by T-cells derived from herpetic lesions or uterine cervix; vaccination
06/26/2003US20030118609 Administering a multimer of a human papillomavirus protein that is truncated at its amino terminus for immunization
06/26/2003US20030118608 Comprising Lelystad Agent in a live, attenuated, dead, or recombinant form
06/26/2003US20030118596 Fusion proteins economically synthesized in plants at high levels by biologically contained tobamoviruses; use as antigens for inducing production of antibodies or as vaccine antigens for induction of immunity against parvovirus
06/26/2003US20030118558 Lysin-deficient bacteriophages having reduced immunogenicity
06/26/2003US20030118553 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and metastases mediated thereof
06/26/2003US20030118551 Modified viral surface proteins for binding to extracellular matrix components
06/26/2003CA2469785A1 Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor
06/25/2003EP1320622A2 Viral vectors having tissue tropism for t-lymphocytes, b- and mast cells
06/25/2003EP1320621A2 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications
06/25/2003EP1320583A2 Enhanced replication of hcv rna
06/25/2003EP1320582A2 Adenovirus e1b-55k single amino acid mutants and methods of use
06/25/2003EP1320540A2 Peptidomimetic protease inhibitors
06/25/2003EP0573603B1 Inhibitors of human neutrophil elastase and human cathepsin g
06/25/2003CN1426477A 方法 Method
06/25/2003CN1426467A Thrombopoietin receptor modulating peptide
06/25/2003CN1426462A Pneumovirus NS proteins antagonising interferon (IFN) response
06/25/2003CN1425467A Method for regulating replication of nonreplication adenovirus
06/25/2003CN1112105C Insect control with multiple toxins
06/24/2003US6583276 Nucleotide sequences coding polypeptide for use in the treatment of cardiovascular disorders
06/24/2003US6583121 System for the in vivo delivery and expression of heterologous genes in the bone marrow
06/24/2003US6582947 Nucleotide sequences coding enzymatic polypeptide for use in the virus treatment of cancer and viral infection
06/24/2003US6582915 Production of anti-self bodies from antibody segment repertories and displayed on phage
06/24/2003US6582693 Recombinant MVA virus expressing the E2 gene of Bovine papillomavirus and its use in the therapy of tumors generated by papillomaviruses
06/24/2003CA2171544C Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains
06/19/2003WO2003050308A1 Highly-sensitive genomic assays employing chimeric bacteriophage standards
06/19/2003WO2003050275A2 Method of isolation and purification of trypsin from pronase and use thereof
06/19/2003WO2003050258A2 Endogenous retrovirus polypeptides linked to oncogenic transformation
06/19/2003WO2003049767A2 Method of large scale production of hepatitis a virus
06/19/2003WO2003049766A2 Method of purifying hepatitis a virus particles and vaccine preparation
06/19/2003WO2003049765A2 Enveloped virus vaccine and method for production
06/19/2003WO2003049764A1 Composition for viral preservation
06/19/2003WO2003049763A1 Composition for the preservation of viruses
06/19/2003WO2003049703A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
06/19/2003WO2003035681A3 Mycobacterial genes down-regulated during latency
06/19/2003US20030115636 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants
06/19/2003US20030115635 Controlling gene expression, apoptosis in plants
06/19/2003US20030115634 Dna sequence from Plasmodium; detection of herbicides, viricides, bactericides, fungicides
06/19/2003US20030115616 Transgenic animal; urokinase plasminogen activator; viricides; detecting liver toxicity
06/19/2003US20030113898 Methods for producing high titre vectors and compositions used in such methods
06/19/2003US20030113717 Directed evolution of novel binding proteins
06/19/2003US20030113348 Non-laboratory strain used in the manufacture of a medicament for the oncolytic treatment of cancer; anticancer agents
06/19/2003US20030113347 Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
06/19/2003US20030113346 Genome which overexpresses G protein to increase apoptosis in infected cells
06/19/2003US20030113295 Methods and compositions for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders
06/19/2003CA2784260A1 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
06/19/2003CA2469589A1 Method of large scale production of hepatitis a virus
06/19/2003CA2469491A1 Composition for viral preservation
06/19/2003CA2469484A1 Method of isolation and purification of trypsin from pronase and use thereof
06/19/2003CA2469049A1 Endogenous retrovirus polypeptides linked to oncogenic transformation
06/19/2003CA2468297A1 Method of purifying hepatitis a virus particles and vaccine preparation
06/18/2003EP1319018A2 Influenza a virus haemagglutinin subtype h16 proteins and their encoding nucleic acid
06/18/2003EP0821739B1 An adenovirus helper-virus system
06/18/2003EP0638124B1 Oral infection of insect larvae with pre-occluded baculovirus particles
06/18/2003CN1425073A 病毒株 Strains
06/18/2003CN1424401A Conditional duplicated adenovirus and its establishment and use
06/17/2003US6579855 Adenovirus-mediated gene therapy
06/17/2003US6579678 Identifying evolved polynucleotides using recursive sequence recombination; recombining overlapping nucleotide sequences; screening for desired property; use in correlating different combinations of mutations with a desired result
06/17/2003US6579676 A population of recombinant cells comprising mutant cDNAs; encode a particular protein which comprises binding domains having different ligands; useful in design of new ligands and drugs
06/17/2003US6579528 Vaccines; genetically engineering
06/17/2003US6579526 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
06/17/2003US6579522 Replication deficient adenoviral TNF vector
06/17/2003CA2118816C Composition for introducing nucleic acid complexes into higher eucaryotic cells
06/17/2003CA2078605C Chicken anaemia agent vaccine
06/12/2003WO2003048348A2 Production of viruses, viral isolates and vaccines
06/12/2003WO2003048197A1 Production and of viruses, viral isolates and vaccines
06/12/2003WO2003047617A2 Vaccine
06/12/2003WO2002068627A3 Vector constucts
06/12/2003US20030109468 Novel compounds that enhance dimerization of the subunits of HIV-1 reverse transcriptase having mutations associated with resistance to nonnucleoside reverse transcriptase inhibitors
06/12/2003US20030109023 HIV-producing cell line and uses thereof
06/12/2003US20030108918 Inactivated vaccines for aids and other infectious diseases
06/12/2003US20030108909 Genetic suppressor elements against human immunodeficiency virus
06/12/2003US20030108861 Comprises serum-free culture; protease-free
06/12/2003US20030108860 Growing high density culture (serum-free) of adherent cells bound to microcarrier (dextran), infecting cells, then incubating
06/12/2003US20030108859 Enveloped virus vaccine and method for production
06/12/2003US20030108569 Novel recombinant and mutant adenoviruses
06/12/2003US20030108562 Administering gag protein; vaccines for human immunodeficiency virus
06/12/2003US20030108561 Core-glycosylated HCV envelope proteins
06/12/2003US20030108560 Chimeric filovirus glycoprotein
06/12/2003US20030108557 Biosynthesis; contacting plant cell with genetic engineered nucleic acid virus; gene expression of fusion protein; splitting using cyanogen bromide
06/12/2003US20030108521 Adenovirus protein IX, its domains involved in capsid assembly, transcriptional activity and nuclear reorganization
06/12/2003CA2467486A1 Vaccine
06/11/2003EP1317559A2 Dna transfection system for the generation of infectious influenza virus
06/11/2003EP1317481A2 Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene
1 ... 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 ... 267